Expertise in
1
conditions

Dr. Robert F. Krywicki

Hematology
Phoebe Putney Memorial Hospital
417 W 3rd Ave, 
Albany, GA 
Accepting New Patients
Expertise in
1
conditions
Phoebe Putney Memorial Hospital
417 W 3rd Ave, 
Albany, GA 

Overview

Robert Krywicki is a Hematologist practicing medicine in Albany, Georgia.

Dr. Krywicki is highly rated in 1 condition, according to our data. His clinical expertise encompasses Essential Thrombocythemia, Chronic B-Cell Leukemia (CBCL), Richter Syndrome, and Chronic Lymphocytic Leukemia (CLL).

He is actively involved in clinical research, participating in 6 clinical trials. Dr. Krywicki is currently accepting new patients.

Specialties

Hematology

Licenses

Internal Medicine in GA

Hospital Affiliations

Phoebe Sumter Medical Center
Phoebe Putney Memorial Hospital

Languages Spoken

English
French
German
Korean
Mandarin
Russian
Spanish
Vietnamese

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alliant Health
  • HMO
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Clover Health
  • INSURANCE PLAN
  • MEDICARE MAPD
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

Phoebe Putney Memorial Hospital
417 W 3rd Ave, Albany, GA 31701

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients With 1-3 Positive Nodes, Hormone Receptor-Positive and HER2-Negative Breast Cancer With Recurrence Score (RS) of 25 or Less. RxPONDER: A Clinical Trial Rx for Positive Node, Endocrine Responsive Breast Cancer
A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients With 1-3 Positive Nodes, Hormone Receptor-Positive and HER2-Negative Breast Cancer With Recurrence Score (RS) of 25 or Less. RxPONDER: A Clinical Trial Rx for Positive Node, Endocrine Responsive Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Drug, Other
Study Drugs: Anastrozole, Exemestane, Letrozole, Systemic Chemotherapy
Study Phase: Phase 3
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Other, Procedure, Biological, Drug
Study Phase: Not Applicable
Randomized Study of Erlotinib Vs Observation in Patients With Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)
Randomized Study of Erlotinib Vs Observation in Patients With Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)
Enrollment Status: Active_not_recruiting
Publish Date: July 02, 2026
Intervention Type: Other, Drug
Study Drug: Erlotinib Hydrochloride
Study Phase: Phase 3
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel With or Without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel With or Without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: May 06, 2026
Intervention Type: Drug, Other
Study Drugs: Carboplatin, Cyclophosphamide, Doxorubicin Hydrochloride, Paclitaxel
Study Phase: Phase 3
Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer
Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: February 10, 2026
Intervention Type: Drug, Other
Study Drugs: Anastrozole, Everolimus, Exemestane, Goserelin Acetate, Letrozole, Leuprolide Acetate, Tamoxifen Citrate
Study Phase: Phase 3
A Randomized Phase III Trial for Surgically Resected Early Stage Non-small Cell Lung Cancer: Crizotinib Versus Observation for Patients With Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
A Randomized Phase III Trial for Surgically Resected Early Stage Non-small Cell Lung Cancer: Crizotinib Versus Observation for Patients With Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
Enrollment Status: Active_not_recruiting
Publish Date: December 19, 2025
Intervention Type: Other, Drug
Study Drug: Crizotinib
Study Phase: Phase 3
View 5 Less Clinical Trials
Similar Doctors
Expertise in
8
conditions
Dr. Betty S. Pace
Hematology | Oncology
Expertise in
8
conditions
Dr. Betty S. Pace
Hematology | Oncology
Referral may be required

Phoebe Putney Memorial Hospital

417 W 3rd Ave, 
Albany, GA 
 (0.1 miles away)
229-312-1000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Betty Pace is a Hematologist and an Oncologist practicing medicine in Albany, Georgia. Dr. Pace is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, and Hemolytic Anemia. Dr. Pace is currently accepting new patients.

Expertise in
29
conditions
Expertise in
29
conditions
Referral may be required

Phoebe Putney Memorial Hospital

417 W 3rd Ave, 
Albany, GA 
 (0.1 miles away)
229-312-1000
Languages Spoken:
English, French, German, Korean, Mandarin, Russian, Spanish, Vietnamese
See accepted insurances
Accepting New Patients

Jose Tongol is a Hematologist practicing medicine in Albany, Georgia. Dr. Tongol is highly rated in 29 conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Richter Syndrome, Chronic B-Cell Leukemia (CBCL), Schnitzler Syndrome, and Bone Marrow Aspiration. Dr. Tongol is currently accepting new patients.

Expertise in
14
conditions
Expertise in
14
conditions
Referral may be required

Phoebe Putney Memorial Hospital Inc.

427 W 3rd Ave, 
Albany, GA 
 (0.1 miles away)
229-312-7141
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Sailaja Gadde is a Hematologist practicing medicine in Albany, Georgia. Dr. Gadde is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Hemoglobin SC Disease, D-Minus Hemolytic Uremic Syndrome, and Hemoglobinopathy. Dr. Gadde is currently accepting new patients.

Frequently Asked Questions about Dr. Robert F. Krywicki

How do I make an appointment with Dr. Robert F. Krywicki?

You can book an appointment with Dr. Robert F. Krywicki by calling their office at 229-312-1000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Robert F. Krywicki a top-rated expert for Essential Thrombocythemia?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Robert F. Krywicki is classified as an Advanced expert for Essential Thrombocythemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Robert F. Krywicki specialize in?

While Dr. Robert F. Krywicki is a Hematology, they have specific expertise in Essential Thrombocythemia, Chronic B-Cell Leukemia (CBCL), and Richter Syndrome. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Robert F. Krywicki accept my insurance?

Dr. Robert F. Krywicki accepts most major insurance plans, including Aetna and Alliant Health. We recommend calling the office directly at 229-312-1000 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Krywicki's expertise for a condition
ConditionClose
      View All 47 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile